IRIS Accounts Production v26.1.0.640 06371580 director 1.9.24 31.8.25 31.8.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh063715802024-08-31063715802025-08-31063715802024-09-012025-08-31063715802023-08-31063715802023-09-012024-08-31063715802024-08-3106371580ns15:EnglandWales2024-09-012025-08-3106371580ns14:PoundSterling2024-09-012025-08-3106371580ns10:Director12024-09-012025-08-3106371580ns10:PrivateLimitedCompanyLtd2024-09-012025-08-3106371580ns10:SmallEntities2024-09-012025-08-3106371580ns10:AuditExempt-NoAccountantsReport2024-09-012025-08-3106371580ns10:SmallCompaniesRegimeForDirectorsReport2024-09-012025-08-3106371580ns10:SmallCompaniesRegimeForAccounts2024-09-012025-08-3106371580ns10:FullAccounts2024-09-012025-08-3106371580ns10:RegisteredOffice2024-09-012025-08-3106371580ns5:CurrentFinancialInstruments2025-08-3106371580ns5:CurrentFinancialInstruments2024-08-3106371580ns5:Non-currentFinancialInstruments2025-08-3106371580ns5:Non-currentFinancialInstruments2024-08-3106371580ns5:ShareCapital2025-08-3106371580ns5:ShareCapital2024-08-3106371580ns5:CapitalRedemptionReserve2025-08-3106371580ns5:CapitalRedemptionReserve2024-08-3106371580ns5:RetainedEarningsAccumulatedLosses2025-08-3106371580ns5:RetainedEarningsAccumulatedLosses2024-08-3106371580ns5:PlantMachinery2024-09-012025-08-3106371580ns5:FurnitureFittings2024-09-012025-08-3106371580ns5:MotorVehicles2024-09-012025-08-3106371580ns5:ComputerEquipment2024-09-012025-08-3106371580ns5:PlantMachinery2024-08-3106371580ns5:FurnitureFittings2024-08-3106371580ns5:MotorVehicles2024-08-3106371580ns5:ComputerEquipment2024-08-3106371580ns5:PlantMachinery2025-08-3106371580ns5:FurnitureFittings2025-08-3106371580ns5:MotorVehicles2025-08-3106371580ns5:ComputerEquipment2025-08-3106371580ns5:PlantMachinery2024-08-3106371580ns5:FurnitureFittings2024-08-3106371580ns5:MotorVehicles2024-08-3106371580ns5:ComputerEquipment2024-08-3106371580ns5:WithinOneYearns5:CurrentFinancialInstruments2025-08-3106371580ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3106371580ns10:Director112024-08-3106371580ns10:Director112023-08-3106371580ns10:Director112024-09-012025-08-3106371580ns10:Director112023-09-012024-08-3106371580ns10:Director112025-08-3106371580ns10:Director112024-08-31
REGISTERED NUMBER: 06371580 (England and Wales)














RJ MEDICAL CONSULTANTS LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 AUGUST 2025






RJ MEDICAL CONSULTANTS LIMITED (REGISTERED NUMBER: 06371580)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 August 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


RJ MEDICAL CONSULTANTS LIMITED

COMPANY INFORMATION
for the Year Ended 31 August 2025







DIRECTOR: Dr R P Jain





REGISTERED OFFICE: 5 Imperial Court
Laporte Way
Luton
Bedfordshire
LU4 8FE





REGISTERED NUMBER: 06371580 (England and Wales)





ACCOUNTANTS: Miller & Co
Chartered Accountants
5 Imperial Court
Laporte Way
Luton
Bedfordshire
LU4 8FE

RJ MEDICAL CONSULTANTS LIMITED (REGISTERED NUMBER: 06371580)

STATEMENT OF FINANCIAL POSITION
31 August 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 83,488 60,136

CURRENT ASSETS
Stocks 36,470 46,856
Debtors 6 461,204 462,959
Cash at bank and in hand 472 472
498,146 510,287
CREDITORS
Amounts falling due within one year 7 344,088 312,984
NET CURRENT ASSETS 154,058 197,303
TOTAL ASSETS LESS CURRENT
LIABILITIES

237,546

257,439

CREDITORS
Amounts falling due after more than one year 8 (34,405 ) (74,040 )

PROVISIONS FOR LIABILITIES (20,872 ) (15,034 )
NET ASSETS 182,269 168,365

CAPITAL AND RESERVES
Called up, paid and allotted share capital 2 2
Capital redemption reserve 2 2
Retained earnings 182,265 168,361
SHAREHOLDERS' FUNDS 182,269 168,365

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

RJ MEDICAL CONSULTANTS LIMITED (REGISTERED NUMBER: 06371580)

STATEMENT OF FINANCIAL POSITION - continued
31 August 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 1 May 2026 and were signed by:





Dr R P Jain - Director


RJ MEDICAL CONSULTANTS LIMITED (REGISTERED NUMBER: 06371580)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 August 2025

1. STATUTORY INFORMATION

RJ Medical Consultants Limited is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling, rounded to the nearest pound.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Income recognition
Income is recognised when goods/services have been delivered to customers such that risks and rewards of ownership have transferred to them.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on cost
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 20% on cost
Computer equipment - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax represents the future tax consequences of transactions and events recognised in the financial statements of current and previous periods. It is recognised in respect of all timing differences, with certain exceptions. Timing differences are differences between taxable profits and total comprehensive income as stated in the financial statements that arise from the inclusion of income and expense in tax assessments in periods different from those in which they are recognised in the financial statements. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date that are expected to apply to the reversal of timing differences. Deferred tax on revalued non-depreciable tangible fixed assets and investment properties is measured using the rates and allowances that apply to the sale of the asset.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

RJ MEDICAL CONSULTANTS LIMITED (REGISTERED NUMBER: 06371580)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 August 2025

3. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2024 - 8 ) .

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Motor Computer
machinery fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 September 2024 448,026 44,782 45,535 44,725 583,068
Additions 73,372 - - 692 74,064
Disposals (10,500 ) - - - (10,500 )
At 31 August 2025 510,898 44,782 45,535 45,417 646,632
DEPRECIATION
At 1 September 2024 417,109 35,534 27,321 42,968 522,932
Charge for year 39,026 1,387 9,107 1,192 50,712
Eliminated on disposal (10,500 ) - - - (10,500 )
At 31 August 2025 445,635 36,921 36,428 44,160 563,144
NET BOOK VALUE
At 31 August 2025 65,263 7,861 9,107 1,257 83,488
At 31 August 2024 30,917 9,248 18,214 1,757 60,136

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 1,598 -
Other debtors 459,606 462,959
461,204 462,959

RJ MEDICAL CONSULTANTS LIMITED (REGISTERED NUMBER: 06371580)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 August 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 174,428 170,108
Hire purchase contracts 40,348 7,611
Trade creditors 76,417 78,615
Taxation and social security 46,943 54,999
Other creditors 5,952 1,651
344,088 312,984

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans 1,667 55,431
Hire purchase contracts 32,738 18,609
34,405 74,040

9. SECURED DEBTS

To secure the bank loan, the Company issued a debenture comprising of fixed and floating charges over all the assets and undertakings of the Company, including all present and future freehold and leasehold property.

In addition, a group guarantee was provided in favour of the Bank from RJ Medical Consultants Ltd and RJ Property Investments Ltd guaranteeing the obligations of each other to the Bank.

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 August 2025 and 31 August 2024:

2025 2024
£    £   
Dr R P Jain
Balance outstanding at start of year 25,374 58,738
Amounts advanced 3,549 108,044
Amounts repaid (25,374 ) (141,408 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 3,549 25,374

11. RELATED PARTY DISCLOSURES

The director operates a loan account with the company, which is repayable on demand. Interest is being charged at the official rate as issued by HMRC. Transactions on this loan account can be found above.